Metabolic syndrome cluster does not provide incremental prognostic information in patients with stable cardiovascular disease: A post hoc analysis of the AIM-HIGH trial
Authors:
- Radmila LyubarovaRLRadmila Lyubarova
- Jennifer G. RobinsonJRJennifer G. Robinson
- Michael MillerMMMichael Miller
- Debra L. SimmonsDSDebra L. Simmons
- Ping XuPXPing Xu
- Beth L. AbramsonBABeth L. Abramson
- Marshall B. ElamMEMarshall B. Elam
- Todd M. BrownTBTodd M. Brown
- Ruth McBrideRMRuth McBride
- Jerome L. FlegJFJerome L. Fleg
- Patrice Desvigne-NickensPDPatrice Desvigne-Nickens
- Woubeshet AyenewWAWoubeshet Ayenew
- 1 September 2017
- journal article
- clinical trial
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 11 (5) , 1201-1211
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (U01 HL081616, U01 HL081649)
This publication has 18 references indexed in Scilit:
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatmentEuropean Heart Journal, 2013
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin TherapyNew England Journal of Medicine, 2011
- Impact of metabolic syndrome on clinical outcomes after new generation drug-eluting stent implantation: The ‘obesity paradox’ phenomenon is still apparentNutrition, Metabolism and Cardiovascular Diseases, 2011
- Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) TrialJACC, 2011
- The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterolAmerican Heart Journal, 2011
- Long-term rates of cardiovascular events in patients with the metabolic syndrome according to severity of coronary-angiographic alterationsCoronary Artery Disease, 2009
- Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II studyCoronary Artery Disease, 2008
- Metabolic Syndrome and Risk of Cardiovascular Events After Myocardial InfarctionJACC, 2005
- Definition of Metabolic SyndromeCirculation, 2004
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985